BALLARINI, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 11.544
AS - Asia 8.592
EU - Europa 6.420
SA - Sud America 1.064
AF - Africa 195
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 13
Totale 27.878
Nazione #
US - Stati Uniti d'America 10.870
SG - Singapore 2.800
CN - Cina 1.796
VN - Vietnam 1.748
IT - Italia 1.580
DE - Germania 1.243
RU - Federazione Russa 874
HK - Hong Kong 845
BR - Brasile 805
SE - Svezia 605
CA - Canada 557
IE - Irlanda 412
GB - Regno Unito 393
FR - Francia 260
IN - India 250
KR - Corea 217
UA - Ucraina 216
FI - Finlandia 170
AT - Austria 136
ID - Indonesia 129
BD - Bangladesh 125
JP - Giappone 116
TR - Turchia 105
AR - Argentina 98
IQ - Iraq 87
DK - Danimarca 78
NL - Olanda 76
MX - Messico 72
PL - Polonia 71
LT - Lituania 67
CH - Svizzera 65
ES - Italia 62
ZA - Sudafrica 60
PK - Pakistan 53
AU - Australia 45
BE - Belgio 44
SA - Arabia Saudita 42
EC - Ecuador 36
PH - Filippine 35
CO - Colombia 33
EG - Egitto 30
UZ - Uzbekistan 29
VE - Venezuela 29
IR - Iran 28
MA - Marocco 25
MY - Malesia 25
PY - Paraguay 22
CL - Cile 20
TW - Taiwan 17
AE - Emirati Arabi Uniti 16
TN - Tunisia 16
IL - Israele 15
KZ - Kazakistan 15
TH - Thailandia 14
ET - Etiopia 13
RO - Romania 13
CR - Costa Rica 12
JO - Giordania 12
BG - Bulgaria 10
EU - Europa 10
KE - Kenya 10
OM - Oman 10
AZ - Azerbaigian 9
CZ - Repubblica Ceca 9
UY - Uruguay 9
AO - Angola 8
HN - Honduras 8
HU - Ungheria 8
NG - Nigeria 8
KW - Kuwait 7
NP - Nepal 7
PE - Perù 7
JM - Giamaica 6
LB - Libano 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
KG - Kirghizistan 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
BH - Bahrain 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
LA - Repubblica Popolare Democratica del Laos 3
MN - Mongolia 3
MT - Malta 3
PA - Panama 3
PT - Portogallo 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BN - Brunei Darussalam 2
CU - Cuba 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
MM - Myanmar 2
MU - Mauritius 2
Totale 27.844
Città #
Ann Arbor 1.946
Singapore 1.691
Dallas 1.121
Ashburn 990
San Jose 870
Frankfurt am Main 832
Hong Kong 802
Milan 603
Ho Chi Minh City 526
Chandler 406
Hanoi 402
Dublin 398
Toronto 385
Wilmington 335
New York 308
Beijing 284
Los Angeles 282
Dearborn 259
Woodbridge 248
Houston 202
Fairfield 192
Jacksonville 189
Santa Clara 179
Chicago 177
Council Bluffs 168
Hefei 168
Seoul 160
Princeton 149
The Dalles 139
Boardman 117
Vienna 114
Shanghai 107
Nanjing 100
Buffalo 97
Seattle 96
Moscow 92
Lauterbourg 91
São Paulo 91
Jakarta 86
Munich 84
Guangzhou 81
Helsinki 77
Orem 73
Da Nang 56
Tokyo 56
Rome 55
Haiphong 53
Dong Ket 51
London 51
Zurich 49
Vilnius 48
Warsaw 48
Montreal 47
Denver 42
Baghdad 39
Chennai 39
Cambridge 38
Carate Brianza 38
Rio de Janeiro 38
Saint Petersburg 38
Turku 37
Altamura 36
Brooklyn 36
Nuremberg 35
Hải Dương 34
Shenyang 34
Lawrence 32
Basingstoke 31
Johannesburg 31
Pune 31
Atlanta 30
Biên Hòa 30
Brussels 30
Lachine 30
Stockholm 30
Ha Long 29
Jinan 28
Kent 28
Ninh Bình 28
Ottawa 28
Phoenix 28
Tashkent 28
Daejeon 27
Nanchang 27
Poplar 27
Changsha 26
Falls Church 26
Florence 26
Fremont 26
Andover 25
Can Tho 25
Mexico City 25
Quận Bình Thạnh 25
Dhaka 24
Manchester 24
Amsterdam 23
Bắc Ninh 23
Columbus 23
Kunming 23
Sacramento 23
Totale 17.635
Nome #
CIPN and its mechanism of development 609
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 600
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 576
In vivo comparative study on acute and sub-acute biological e_ects induced by ultrafine particles of different anthropogenic sources in balb/c mice 555
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 501
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 492
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 483
Systemic exposure to air pollution induces oxidative stress and inflammation in mouse brain, contributing to neurodegeneration onset 468
miRNAs Affect the Expression of Innate and Adaptive Immunity Proteins in Celiac Disease 465
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 447
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 443
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 425
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 420
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 417
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 415
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 411
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 410
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 404
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 397
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 351
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 336
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 333
Age and Sex Influence the Neuro-inflammatory Response to a Peripheral Acute LPS Challenge 333
miR-192-5p and CXCL2/NOD2 inverse correlation in celiac disease 321
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 316
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 312
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 311
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 303
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 302
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 302
Effects induced by particles derived from two anthropogenic sources on respiratory, cardiovascular and central nervous systems 299
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 297
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 296
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 289
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 287
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 284
Multiple Sclerosis Drug Therapy: from the Classical Pharmaceutical down to Cellular and Molecular Approach 283
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 277
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 274
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 273
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 273
Histone deacetylases inhibitors: a new frontier for neuroprotection? 271
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 270
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 267
Establishing sample-preparation protocols for X-ray phase-contrast CT of rodent spinal cords: Aldehyde fixations and osmium impregnation 267
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 267
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 263
Therapeutic potential of Mesenchymal Stem Cells for the treatment of type-1 Diabetes. 262
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 260
Caratterizzazione di un modello di encefalomielite autoimmune sperimentale e ruolo neuroprotettivo del progesterone 260
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 258
MSCs effect on Dark Agouti rats affected by chronic EAE 256
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 255
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 253
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 253
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 251
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 250
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 248
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 245
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 244
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 243
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 243
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 242
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 234
Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis 231
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 227
EXPLOITING HDAC6 SPECIFIC INHIBITORS TO REDUCE OHP-INDUCED NEUROTOXICITY 226
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 226
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 223
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 221
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation 220
Multimodal Analysis in Acute and Chronic Experimental Autoimmune Encephalomyelitis 219
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 218
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 217
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 215
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 214
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 212
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 212
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 208
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 207
Bioresponsive Hyaluronic Acid-Based Hydrogel Inhibits Matrix Metalloproteinase-2 in Glioblastoma Microenvironment 201
Nose-to-brain delivery of polymeric nanoparticles 200
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 199
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 197
Making Connections: Mesenchymal Stem Cells Manifold Ways to Interact with Neurons 196
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 188
ERK1 and ERK2 involvement in human Mesenchymal Stem Cells adipogenic differentiation 185
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 166
Changes in neuroactive steroids in experimental autoimmune encephalomyelitis 165
Effects of bortezomib-induced peripheral neuropathy on HSP27, HSP60 and HSP90 levels in the sciatic nerve 161
Sodium/calcium exchanger (NCX): axonal damage as a consequence of functional disturbances. A new target for neuroprotection? 153
UNVEILING THE MICROVASCULAR NETWORK ALTERATIONS IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF RATS EXPOSED TO NEUROTOXIC CHEMOTHERAPY 150
CHARACTERIZATION OF NEW MURINE MODELS OF PERIPHERAL NEUROPATHY INDUCED BY CHRONIC ADMINISTRATION OF ANTINEOPLASTIC COMPOUNDS 145
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 140
Blood NfL as a potential axonal damage marker in different CIPN rat models. 132
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 130
SODIUM-CALCIUM EXCHANGER PIVOTAL ROLE IN OXALIPLATIN-INDUCED ALTERATIONS LEADING TO PERIPHERAL NEUROTOXICITY, AXONAL DAMAGE AND NECROPTOSIS 110
MALDI mass spectrometry imaging for in situ analysis of DRGs: Oxaliplatin modifies the tissue proteome 109
The different susceptibility to oxaliplatin neurotoxicity in mice is related to change in expression of the anion exchanger SLC4A1 103
Interleukin-6 as a keystone cytokine in experimental rat models of chemotherapy-induced peripheral neurotoxicity 99
Totale 28.077
Categoria #
all - tutte 84.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021316 0 0 0 0 0 0 0 0 0 0 123 193
2021/20221.294 104 117 107 137 118 139 56 71 51 80 103 211
2022/20232.289 217 531 299 238 208 324 57 105 138 40 63 69
2023/20241.731 59 65 61 119 197 362 307 98 101 47 57 258
2024/20254.837 262 463 436 226 389 210 327 202 551 673 438 660
2025/202612.825 1.881 1.106 1.613 1.198 1.135 732 1.813 615 1.054 1.055 623 0
Totale 28.839